carfilzomib
(kar-FIL-zoh-mib)
A drug used alone or with other drugs to treat adults with multiple myeloma that came back or did not get better after treatment with one or more other therapies. It is also being studied in the treatment of other types of cancer. Carfilzomib blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called Kyprolis.